All posts by: Michael Zand

About Michael Zand

Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects – Newswise (press release)

Continue reading

2017-11-22 NEWS

Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects
Newswise (press release)
Cancer immunotherapy — treatment that harnesses the patient’s own immune system to recognize and fight cancer — has become a pillar of cancer care in recent years. One widely used class of agents, checkpoint inhibitors, works by “taking the brakes

Continue reading

2017-11-22 NEWS

The Sydney Morning Herald

‘Are you scared of dying, dad?’: the constant uncertainty of immunotherapy
The Sydney Morning Herald
Ian Cant and his daughter Demi, 12, both addressed the Cancer Oncology Society of Australia’s conference in Sydney to discuss the effects of his immunotherapy treatment for metastatic melanoma. Photo: Jessica Hromas. “I would get really anxious and …

and more »

Continue reading

2017-11-22 NEWS

The Sydney Morning Herald

‘Are you scared of dying, dad?’: the constant uncertainty of immunotherapy
The Sydney Morning Herald
Ian Cant and his daughter Demi, 12, both addressed the Cancer Oncology Society of Australia’s conference in Sydney to discuss the effects of his immunotherapy treatment for metastatic melanoma. Photo: Jessica Hromas. “I would get really anxious and …

and more »

Continue reading

2017-11-22 NEWS

STAT

What will FDA’s new rules mean for legitimate stem cell treatments?
STAT
hen the Food and Drug Administration last week 1 issued guidelines for investigative stem cell therapies, much of the attention fell to the agency’s vow to crack down further 2 on unregulated clinics 3 offering potentially unsafe treatments. But the

Continue reading

2017-11-22 NEWS

OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee’s annual …
News-Medical.net
Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the …